← Back to All US Stocks

MODD Stock Analysis 2026 - Modular Medical, Inc. AI Rating

MODD Nasdaq Surgical & Medical Instruments & Apparatus NV CIK: 0001074871
Recently Updated • Analysis: Apr 2, 2026 • SEC Data: 2025-12-31
STRONG SELL
95% Conf
Pending
Analysis scheduled

📊 MODD Key Takeaways

Revenue: $16.0
Net Margin: -136,575,000.0%
Free Cash Flow: $-20.9M
Current Ratio: 1.59x
Debt/Equity: 0.00x
EPS: $-0.37
AI Rating: STRONG SELL with 95% confidence

Is MODD a Good Investment? Thesis Analysis

Claude

Modular Medical exhibits severe fundamental distress with massive operating losses (-$21.9M), negative cash flow generation (-$20.9M), and profitability margins in the millions of percent negative range. The company is burning cash while generating minimal revenue, indicating fundamental business model dysfunction rather than temporary operational challenges.

Why Buy MODD? Key Strengths

Claude
  • + Positive current ratio of 1.59x indicates near-term liquidity capacity to cover obligations
  • + Zero debt burden eliminates leverage risk and solvency concerns
  • + Cash position of $2.9M provides runway for operations

MODD Investment Risks to Consider

Claude
  • ! Operating cash outflow of -$17.9M annually is unsustainable with current asset base; company will deplete cash within months at current burn rate
  • ! Revenue of $16M against $21.9M operating losses indicates severe cost structure problem and inability to achieve profitability at current scale
  • ! Negative free cash flow of -$20.9M combined with ongoing capital expenditure of $2.9M demonstrates capital is being destroyed rather than generated
  • ! Extreme profitability metrics (operating margin -136731250%, net margin -136575000%) suggest systemic operational dysfunction
  • ! Diluted EPS of -$0.37 shows per-share value destruction despite modest YoY improvement

Key Metrics to Watch

Claude
  • * Operating cash flow trajectory - critical survival metric given current negative -$17.9M burn rate
  • * Revenue growth sustainability and gross margin realization - minimal revenue with zero gross profit indicates fundamental product/pricing dysfunction
  • * Cash depletion timeline - with $2.9M cash and -$20.9M annual FCF burn, runway is approximately 1.7 months

MODD Financial Metrics

Revenue
$16.0
Net Income
$-21.9M
EPS (Diluted)
$-0.37
Free Cash Flow
$-20.9M
Total Assets
$10.3M
Cash Position
$2.9M

💡 AI Analyst Insight

Modular Medical, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.

MODD Profitability Ratios

Gross Margin 0.0%
Operating Margin -136,731,250.0%
Net Margin -136,575,000.0%
ROE -371.6%
ROA -213.0%
FCF Margin -130,406,250.0%

MODD vs Healthcare Sector

How Modular Medical, Inc. compares to Healthcare sector averages

Net Margin
MODD -136,575,000.0%
vs
Sector Avg 12.0%
MODD Sector
ROE
MODD -371.6%
vs
Sector Avg 15.0%
MODD Sector
Current Ratio
MODD 1.6x
vs
Sector Avg 2.0x
MODD Sector
Debt/Equity
MODD 0.0x
vs
Sector Avg 0.6x
MODD Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is MODD Overvalued or Undervalued?

Based on fundamental analysis, Modular Medical, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
-371.6%
Sector avg: 15%
Net Profit Margin
-136,575,000.0%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.00x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

MODD Balance Sheet & Liquidity

Current Ratio
1.59x
Quick Ratio
1.59x
Debt/Equity
0.00x
Debt/Assets
42.7%
Interest Coverage
-7.95x
Long-term Debt
N/A

MODD 5-Year Financial Trend & Growth Analysis

MODD 5-year financial data: Year 2014: Revenue $1.4K, Net Income N/A, EPS N/A. Year 2015: Revenue $0, Net Income N/A, EPS N/A. Year 2016: Revenue $0, Net Income N/A, EPS N/A. Year 2017: Revenue $0, Net Income N/A, EPS N/A. Year 2018: Revenue $0, Net Income N/A, EPS N/A.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Modular Medical, Inc.'s revenue has declined by 100% over the 5-year period, indicating business contraction. The most recent EPS of $-0.78 indicates the company is currently unprofitable.

MODD Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-130,406,250.0%
Free cash flow / Revenue

MODD Quarterly Performance

Quarterly financial performance data for Modular Medical, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2019 N/A -$258.8K N/A
Q2 2019 N/A -$176.0K N/A
Q1 2019 N/A -$38.7K N/A
Q3 2018 N/A -$6.4K N/A
Q2 2018 N/A -$1.1K N/A
Q3 2017 N/A -$6.7K N/A
Q2 2017 N/A -$6.9K N/A
Q1 2017 N/A -$11.0K N/A

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

MODD Capital Allocation

Operating Cash Flow
-$17.9M
Cash generated from operations
Capital Expenditures
$2.9M
Investment in assets
Dividends
None
No dividend program

MODD SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for Modular Medical, Inc. (CIK: 0001074871)

📋 Recent SEC Filings

Date Form Document Action
Mar 31, 2026 8-K ea0283929-8k_modular.htm View →
Mar 13, 2026 8-K ea0281485-8k_modular.htm View →
Mar 6, 2026 8-K ea0280388-8k_modular.htm View →
Feb 27, 2026 S-1 ea0278138-s1_modularmedical.htm View →
Feb 24, 2026 8-K ea0278049-8k_modular.htm View →

Frequently Asked Questions about MODD

What is the AI rating for MODD?

Modular Medical, Inc. (MODD) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.

What are MODD's key strengths?

Claude: Positive current ratio of 1.59x indicates near-term liquidity capacity to cover obligations. Zero debt burden eliminates leverage risk and solvency concerns.

What are the risks of investing in MODD?

Claude: Operating cash outflow of -$17.9M annually is unsustainable with current asset base; company will deplete cash within months at current burn rate. Revenue of $16M against $21.9M operating losses indicates severe cost structure problem and inability to achieve profitability at current scale.

What is MODD's revenue and growth?

Modular Medical, Inc. reported revenue of $16.0.

Does MODD pay dividends?

Modular Medical, Inc. does not currently pay dividends.

Where can I find MODD SEC filings?

Official SEC filings for Modular Medical, Inc. (CIK: 0001074871) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is MODD's EPS?

Modular Medical, Inc. has a diluted EPS of $-0.37.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is MODD a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Modular Medical, Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is MODD stock overvalued or undervalued?

Valuation metrics for MODD: ROE of -371.6% (sector avg: 15%), net margin of -136,575,000.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy MODD stock in 2026?

Our dual AI analysis gives Modular Medical, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is MODD's free cash flow?

Modular Medical, Inc.'s operating cash flow is $-17.9M, with capital expenditures of $2.9M. FCF margin is -130,406,250.0%.

How does MODD compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -136,575,000.0% (avg: 12%), ROE -371.6% (avg: 15%), current ratio 1.59 (avg: 2).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 2, 2026 | Data as of: 2025-12-31 | Powered by Claude AI